Holen Sie sich die Stockscreener-App
62.51
0.53%
-0.3145
Schlusskurs vom Vortag:
$62.82
Offen:
$62.32
24-Stunden-Volumen:
7.65M
Relative Volume:
0.50
Marktkapitalisierung:
$93.03B
Einnahmen:
$20.08B
Nettoeinkommen (Verlust:
$2.89B
KGV:
32.23
EPS:
1.9391
Netto-Cashflow:
$3.66B
1W Leistung:
-0.70%
1M Leistung:
-12.42%
6M Leistung:
-35.38%
1J Leistung:
-30.34%
1-Tages-Spanne:
$62.18
$63.30
1-Wochen-Bereich:
$61.44
$64.23
52-Wochen-Spanne:
$61.24
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
62.59 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
ABT
Abbott Laboratories
|
102.15 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.01 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.25 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-30 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific (BSX) Price Target Lowered by Evercore ISI Gro - gurufocus.com
Boston Scientific closes buyout of Valencia Technologies - MedTech Dive
BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Piper Sandler maintains Boston Scientific stock rating after device feedback - investing.com
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Nike, Boston Scientific, And Sysco Are Among Top 10 Large Cap Losers Last Week (March 30-April 2): Are th - Benzinga
Boston Scientific Corporation (BSX) Stock Price, News, Quote & History - Yahoo! Finance Canada
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Why Boston Scientific's big dip could be a bigger opportunity - MSN
Boston Scientific beats Q4 estimates, shares dip slightly - Investing.com
Boston Scientific Corp. Stock: Strong Growth in Medtech Amid Evolving Healthcare Demands - AD HOC NEWS
Boston Scientific Corp. stock outperforms competitors on strong trading day - marketwatch.com
Boston Scientific completes acquisition of California bladder treatment company - Worcester Business Journal
BSX Shareholders Have Opportunity to Lead Boston Scientific Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - ChartMill
INVESTOR DEADLINE: Boston Scientific Corporation (BSX) - GlobeNewswire
RBC Capital reiterates Boston Scientific stock rating on growth outlook By Investing.com - Investing.com India
RBC Capital reiterates Boston Scientific stock rating on growth outlook - Investing.com
Here are the largest manufacturers in Massachusetts - The Business Journals
Banque Pictet & Cie SA Has $25.83 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
BSX Price History for Boston Scientific Corp Stock - Barchart.com
[EFFECT] BOSTON SCIENTIFIC CORP SEC Filing - Stock Titan
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - marketwatch.com
Boston Scientific (NYSE: BSX) to acquire Penumbra in $374/share deal - Stock Titan
Boston Scientific (BSX) Says CHAMPION-AF Trial Meets All Primary Endpoints - Insider Monkey
Boston Scientific (XSWX:BSX) Shiller PE Ratio : (As of Apr. 01, 2026) - GuruFocus
Nisa Investment Advisors LLC Sells 18,182 Shares of Boston Scientific Corporation $BSX - MarketBeat
List of 57 Acquisitions by Boston Scientific (Apr 2026) - Tracxn
Stocks making big moves yesterday: Avis Budget Group, Boston Scientific, CLEAR Secure, DNOW, and Comcast - Yahoo Finance
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - ChartMill
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
Boston Scientific presents Watchman FLX and EKOS endovascular system data - Medical Device Network
FDA clears Boston Scientific’s Asurys system for endoscopic procedures - Medical Device Network
UBS reiterates Boston Scientific stock Buy on trial success - investing.com
Boston Scientific (BSX) Stock Plunges 9% on Watchman Trial Concerns and Rating Cut - Blockonomi
Boston Scientific (BSX) Stock Falls 9% After Watchman Trial Data and Analyst Downgrade - CoinCentral
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Abbott Laboratories (ABT) - theglobeandmail.com
Jefferies Keeps Their Buy Rating on Boston Scientific (BSX) - theglobeandmail.com
Boston Scientific (BSX) Gets a Buy from Canaccord Genuity - theglobeandmail.com
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
BSX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
BSX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Boston Scientific Corporation Securities Lawsuit -- The Gross Law Firm - PR Newswire
Boston Scientific Stock Sinks to 2-Year Low. Why Wall Street Is Souring on Trial Data. - Barron's
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
AI Models Turn More Positive on Boston Scientific, But Weak Technicals Temper Enthusiasm - TipRanks
Boston Scientific (BSX) Receives a Buy from RBC Capital - theglobeandmail.com
Boston Scientific Stock Tumbles 9% Following Raymond James Downgrade - TIKR.com
Can Boston Scientific Stock Surge 40% From Here? - Yahoo Finance
Is There An Opportunity In Boston Scientific (BSX) After Steep Recent Share Price Declines? - simplywall.st
Boston Scientific Corporation $BSX Stock Holdings Cut by J. Safra Sarasin Holding AG - MarketBeat
Boston Scientific dives after disappointing clinical trial results - medwatch.com
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.50%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):